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1. Introduction
  Pulmonary blastoma (PB) is a very rare pulmonary 
neoplasm, accounting for 0.25% to 0.5% of primitive 
malignant tumors of the lung. Since 1945, only over 200 
cases of PB have been reported worldwide[1]. PB is classified 
into two types, adult type and child type. From April 1989 
to April 2013, 18 adult cases were admitted in our hospital, 
accounting for 0.21% (18/8 531) of patients with malignant 
pulmonary tumors. We retrospectively reviewed the clinic 
features of these 18 PB cases.  
2. Case report
2.1. Demographics 
  A total of 18 patients including 11 men and 7 women were 
selected, aged 45 to 76 years, with a median of 53 years. All 
male patients and one female patient had smoking history. 
Fifteen PB patients had cough, bloody phlegm, chest pain, 
and chest tightness. Other 3 patients showed no clinical 
manifestation, all lesions were found during physical 
examination. 
2.2. Diagnosis
  Initial chest radiographs and CT scans of all 18 PB patients 
showed round, oval or lobulated mass (Figure 1-4).  Lesions 
of 15 PB patients were located in the peripheral lung, while 
it was located close to hilum in the rest three patients. Six 
PB patients had tumors with smooth margin, and the other 
The clinical data of 18 patients with PB from April 1989 to April 2013 was analyzed retrospectively, 
including 11 men and 7 women, aged 45 and 76 years old (mean 53 years). There were 12 cases of 
PB occurring in right lung and other cases in left lung. Among them, 3 patients had no symptoms, 
and 15 patients displayed symptoms of cough, chest pain, asthenia or minor haemoptysis. 
Overall, 11 patients had a preoperative diagnosis of lung cancer, 7 patients were preoperatively 
diagnosed as the other diseases, which included lung benign tumor (n=5) and mediastinal mass 
(n=2). All patients received a radical resection. Six patients received postoperative cisplatin-
based chemotherapy, and two patients received postoperative irradiation with the dose of 55 Gy. 
Histologically, 14 cases of 18 patients had biphasic pulmonary blastoma and four cases had well 
differentiated fetal adenocarcinoma. A total of 12 patients died in a period of 6-36 months after 
operation, and 1 case was lost after 2 years of follow up. The median survival time was 19 months. 
PB is a rare primary lung malignant embryonal neoplasm. Despite its assumed embyonal origin, 
the tumor has a predilection for adults. A preoperative correct diagnosis is very difficult in spite 
of modern diagnostic imaging and biopsy techniques. Surgical resection is the main method for 
diagnosis and treatment. Postoperative chemotherapy or irradiation can help eliminate tumor 
remnants. Its prognosis is very poor, especially for the biphasic type.
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12 with lobulated margin.  Sixteen lesions were manifested 
as solitary mass, and the other lesion as multiple nodules. 
The widest diameter of the tumors ranged from 2 cm to 12 cm.
In our study, PET-CT examination was conducted on three 
patients, showing abnormal radioactive enrichment on 
lesions with standard uptake value over 4.0. Five cases had 
enlarged hilar lymph node. Five cases had tumors in the 
right upper lobe, one in the right middle lobe, five in the 
right lower lobe, three in the left upper lobe, two in the left 
lower lobe, one in the right posterior inferior mediastinum 
and one in the left anterior mediastinum. Eleven cases were 
preoperatively diagnosed as lung cancers, among which 
three cases had undifferentiated carcinoma confirmed by 
CT-guided biopsy, two case had adenocarcinoma confirmed 
by bronchofibroscopy, five cases were preoperatively 
diagnosed as benign lung tumor, and two cases were 
preoperatively diagnosed as mediastinal tumor. Patients who 
were preoperatively diagnosed as right posterior inferior 
mediastinal tumor also received ultrasound endogastroscopy. 
It showed that the tumor was 25 cm to 30 cm away from 
incisor. The regional esophageal mucosa was smooth and 
complete, and the lumen was slightly narrowed. Outside the 
esophageal wall, there was a hyperechoic mass with uneven 
echo density and unclear border to local lung tissue.  
Figure 1. Chest film of Biphasic PB in left upper lobe.     
  
Figure 2. CT scan of Biphasic PB in left upper lobe. 
Figure 3. Chest film of WDFA in right lower lobe.          
 
Figure 4. CT scan of WDFA in right lower lobe.           
2.3. Treatment
  All patients underwent surgery. A total of 15 cases had 
pulmonary lobectomy combined with hilar and mediastinal 
lymphadenectomy; one case had partial wedge resection 
of pulmonary lesions additional to residual lobectomy 
combined with hilar and mediastinal lymphadenectomy 
half year later due to reoccurrence; two cases had left 
pneumonectomy combined with hilar and mediastinal 
lymphadenectomy considering invasion of the left lower 
lobe tumor to the left upper lobe causing multiple nodules 
formation. Six patients received four to six cycles of adjuvant 
chemotherapy after surgery, of which three took vinorelbine/
cisplatin, two had vinorelbine/ifosfamide, and one had 
ifosfamide/cisplatin. Two cases underwent 55 Gy radiation 
therapy due to brain metastases. All cases had successful 
surgery. The average hospitalization time was 12 days. 
Twelve patients with pulmonary blastoma died 6-36 months 
after the surgery, and one case was lost after two years 
of follow up. The remaining five patients were still alive. 
Median overall survival was 19 months.
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2.4. Pathological analysis
  A total of 15 cases had tumors in the peripheral lung near 
visceral pleura, unconnected to bronchus. Three cases 
had tumor adjacent to hilum, which did not infiltrate into 
bronchus. Fourteen cases had tumor without capsule, and 
4 cases with pseudocapsule. The diameters of all tumors 
ranged from 2 cm to 12 cm (mean, 7.3 cm). The sectional 
surface of the tumors was greyish and fish-like in texture. 
Three cases had hemorrhage and necrosis inside the tumors, 
and five cases had hilar lymph node enlargement.  
  Microscope showed biphasic pulmonary blastoma 
composed of immature epithelium and mesenchyme. 
A monolayer of cuboidal epithelial cells was lined up 
into a small duct-like structure, dispersing among the 
immature mesenchyme cells that were in round or short-
spindle shape with possible mucoid degeneration (Figure 
5). Immunohistochemical assays for biphasic pulmonary 
blastoma were positive for both cytokeratin and vimentin 
(Figure 6).  
Figure 5. Morphology of biphasic PB by HE (10×10).    
Figure 6. Morphology of biphasic PB by IHC (10×10).                                     
  
  Well differentiated fetal adenocarcinoma was observed, 
composed of pseudo stratified tall-columnar adenoid 
epithelial tissue, in duct-like structure similar to fetal 
lung tubules. The tumor cytoplasm was enriched with 
glycogen and also dotted with several vacuoles (Figure 7). 
Immunohistochemical assays for embryotic adenocarcinoma 
were positive for both cytokeratin and vimentin (Figure 8).  
Figure 7. Morphology of WDFA by HE (10×10).   
   
Figure 8. Morphology of WDFA by IHC (10×10).  
  A total of 14 patients were diagnosed as biphasic 
pulmonary blastoma, and 4 patients as well differentiated 
fetal adenocarcinoma.  
3. Discussion
3.1. Clinical features of PB
3.1.1. Etiology
  Until now, there is still no agreement on the histological 
origin of pulmonary blastoma[1]. Spencer[2] suggested that the 
tumor stemmed from the primitive multifunctional stromal 
lung blastema (pulmonary blast cell). The genesis of adult PB 
is probably correlated to smoking. Macher-Goppinger et al[3] 
proved that P53 and 毬-catenin mutation play an important 
role in the genesis of adult PB.  Childhood pulmonary 
blastoma (CPB) is immunologically and cytogenetically 
similar to embryonal rhabdomyosarcoma, indicating that 
CPB may be associated with partial chromosome deletion[4]. 
Therefore, it is still unknown as to the causes of PB, which 
requires further studies and researches. 
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3.1.2 Clinical manifestations: 
  The clinical manifestations of adult PB were not distinctive, 
mostly being cough, chest pain, hemoptysis, and dyspnea. 
40% of the patients with adult PB were asymptomatic[5]. 
Adult PB thus could not easily been differentiated from other 
lung tumors, either benign or malignant.  
3.1.3. Imaging features
  For PB patients, chest radiograph usually shows some 
isolated nodules shadow in the peripheral lung, and CT 
scans reveal solitary parenchymal mass which could be 
enhanced by contrast-enhanced CT scans, with possible 
necrosis. The incidence of PB in the left lung and that in the 
right lung was insignificantly different[1,6]. 66.7% (12/18) of 
our patients had their tumors on the right lung, which was 
not statistical significant because of the small amount of 
cases. It was possible for patients with pulmonary blastoma 
to experience hilum or mediastinal lymph node metastatic 
enlargement, and there was only five such cases in our 
study. This result might further indicate that the major way 
of reoccurring or metastasizing was direct invasion or blood 
metastasis for adult pulmonary plastoma.
3.1.3. Auxiliary examination
  A few PB patients could be pathologically diagnosed 
by preoperative biopsy with either bronchoscopy or CT-
guided tumor puncture. However, the pathological results 
of preoperative biopsy were often misinterpreted as 
adenocarcinoma or sarcoma of the lung due to the diversity 
of tumor tissue and the scarcity of sample tissue. Even 
with advanced imaging and biopsy techniques, it was still 
hardly possible to make confirmed preoperative diagnosis 
concerning PB[7].  
3.1.4. Pathological classification of PB
  Barrett and Barnard[8] firstly named PB as pulmonary 
embryoma in 1945, because of its pathological resemblance 
to embryonic lung. In 1961, Spencer et al[2] found that PB 
was similar to nephroblastoma under the microscope, and 
first used the term pulmonary blastoma, which is still in use 
up to now.
  PB was classified into two types, adult type and child 
type. Child PB was commonly seen in children less than 10 
years old averaged three years, and composed of malignant 
mesenchymal tissue[9]. Adult PB mostly happened in adults 
in their 18 to 70 years averaged 40 years[10,11]. The tumor 
had no clear boundaries to other lung tissues usually with 
complication of hemorrhage and necrosis, and the tumor’s 
sectional surface was often greyish and fish-like in texture. 
Adult PB was either biphasic or epithelial. Biphasic PB was 
constituted of malignant primitive epithelial component and 
primitive mesenchymal component. Epithelial PB was made 
up of primitive components resembling well differentiated 
embryotic adenocarcinoma, and thus was also referred to as 
well differentiated fetal adenocarcinoma[11,12].  
3.2. Treatment for PB
3.2.1.Surgery
  PB was comprehensively treated with surgery. Since PB 
was unsusceptible to radiation and chemotherapy, the 
extent to which PB was radically excised was decisive 
to prognosis[1,5,13]. Main surgery included lobectomy 
and complete pneumonectomy. To reduce postoperative 
reoccurrence rate, local tumor resection should be avoided, 
unless cardiopulmonary function was inadequate and thus 
could not tolerate lobectomy and complete pneumonectomy. 
Pleura, nerve, pericardium or chest wall adjacent to tumors, 
if infiltrated, should also be resected. When the tumor 
infiltrated into big arteries or veins, vascular replacement 
surgery should be performed with the help of specialist to 
achieve radical excision.  
  One patient was preoperatively diagnosed as left upper 
lobe peripheral lung cancer. During the surgery, the frozen 
section procedure showed inflammatory granuloma, so 
we also performed partial wedge resection. However, the 
postoperative pathological report read biphasic pulmonary 
blastoma. To avoid reoccurrence, the patient received four 
cycles of chemotherapy, but still half a year later local 
reoccurrence in left upper lobe was found on CT scan. The 
second surgery was followed, including left upper lobectomy 
and hilar and mediastinal lymphadenectomy, without other 
adjuvant therapies. Two years of follow-up did not find any 
sign of reoccurrence.  
  There was a probable chance that PB would metastasize 
to lymph nodes,  and thus hilar  and mediastinal 
lymphadenectomy was absolutely necessary, which could 
also provide scientific evidences for postoperative adjuvant 
therapy. For PB patients, then the same surgery as to non-
small cell lung cancer should be chosen, i.e. lobectomy 
or pneumonectomy together with hilar and mediastinal 
lymphadenectomy[1,6].
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3.2.2. Radiation and chemotherapy
  There was mostly no literature on choosing single 
chemotherapy or radiation for PB. Meanwhile, no agreement 
was reached on adjuvant chemotherapy or radiation schema. 
Many researchers believed that adjuvant chemotherapy or 
radiation was unbeneficial to PB patients’ overall survival 
rate[1,6,12]. For PB patients with brain metastasis, radiation 
therapy might relieve unpleasant symptoms, but be of no 
long-term efficacious benefit[14].  
  In our study, six cases, five biphasic PB and one WDFA, 
received four to six cycles of adjuvant chemotherapy. The 
six patients died of lung or bone metastasis between 11 
and 36 months. Two cases with biphasic PB underwent
55 Gy radiation therapy due to postoperative brain metastasis 
and died of brain metastasis 6 months and 27 months later 
respectively. For other patients without chemotherapy 
or radiation, one patient had well differentiated fetal 
adenocarcinoma, and the tumor free survival time had been 
155 months. Due to the low incidence and thus inadequate 
numbers of PB patients, there was still no standard 
comprehensive treatment schema for PB.  
3.2.3. Prognosis
  The prognosis was not encouraging since two the third of 
patients were dead two years after diagnosis and the five 
year survival rate was only 16.5% to 55.6%, even though 
there were some cases reported with a quite long survival. 
Clinically, there is still no consensus on factors influencing 
on PB patients’ prognosis.  Overwhelming majority of 
researchers claimed that the factors might be themorphology 
of PB cell, its pathological type and stage, and the extent to 
which the tumor has been surgically resected[1,15,16].  
  In our study, median overall survival rate was 19 months, 
but individual difference was huge with the shortest being 
half a year and the longest being 155 months. Due to the 
small number of cases, statistical analysis was unfeasible for 
our study. Primarily, we would conclude that PB patient’s 
prognosis was partially influenced by the pathological type 
and stage, and determined by the radical resection surgery. 
In short, with little cases of PB reported both home and 
abroad and no authoritative reviews, PB’s morphology and 
factors influencing its prognosis still require further studies. 
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